Skip to content
15% off your first order15% off your first order

Ipamorelin vs Sermorelin

Ipamorelin and Sermorelin are both peptides studied for stimulating growth hormone release, but they act through different receptors. Ipamorelin is a selective growth hormone secretagogue described as a ghrelin receptor (GHS-R1a) agonist, examined for releasing growth hormone with minimal effect on cortisol or prolactin. Its primary studies are animal studies of growth hormone release and bone growth. Sermorelin is a synthetic GHRH analog that acts at the GHRH receptor (GHRH-R). Published reviews describe its clinical use in the diagnosis and treatment of idiopathic growth hormone deficiency in children, and it continues to be discussed in research on adult-onset growth hormone insufficiency. Human safety data are limited for Ipamorelin, and for Sermorelin outside pediatric research.